OM

Opaleye Management Portfolio holdings

AUM $494M
This Quarter Return
+72%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.28%
AUM
$766M
AUM Growth
+$766M
Cap. Flow
+$40.1M
Cap. Flow %
5.24%
Top 10 Hldgs %
55.55%
Holding
68
New
13
Increased
17
Reduced
11
Closed
9
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SRRA
51
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$1.21M 0.16%
+75,379
New +$1.21M
AMRN
52
Amarin Corp
AMRN
$311M
$1.1M 0.14%
11,250
FULC icon
53
Fulcrum Therapeutics
FULC
$353M
$1.03M 0.14%
88,300
-363,700
-80% -$4.26M
GYRE icon
54
Gyre Therapeutics
GYRE
$734M
$939K 0.12%
+19,840
New +$939K
AKUS
55
DELISTED
Akouos, Inc. Common Stock
AKUS
$901K 0.12%
+45,459
New +$901K
ATXS icon
56
Astria Therapeutics
ATXS
$372M
$402K 0.05%
+31,292
New +$402K
DNTH icon
57
Dianthus Therapeutics
DNTH
$781M
$375K 0.05%
+2,988
New +$375K
AVEO
58
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$339K 0.04%
+58,800
New +$339K
BLRX
59
BioLineRX
BLRX
$15.5M
$42K 0.01%
417
CDTX icon
60
Cidara Therapeutics
CDTX
$1.61B
-48,533
Closed -$2.77M
CRNX icon
61
Crinetics Pharmaceuticals
CRNX
$3.26B
-240,000
Closed -$3.76M
NERV icon
62
Minerva Neurosciences
NERV
$16.8M
-95,925
Closed -$2.44M
OM icon
63
Outset Medical
OM
$245M
-3,000
Closed -$2.25M
SYRE icon
64
Spyre Therapeutics
SYRE
$1.02B
-15,000
Closed -$2.66M
XFOR icon
65
X4 Pharmaceuticals
XFOR
$70M
-2,500
Closed -$508K
PVLA
66
Palvella Therapeutics, Inc. Common Stock
PVLA
$592M
-1,813
Closed -$300K
ATXI
67
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
-875
Closed -$10.7M
ONCT
68
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
-9,727
Closed -$331K